167 filings
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
20 Apr 20
Bankruptcy or Receivership
7:50am
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
14 Apr 20
In the United States Bankruptcy Court for the District of Delaware
5:27pm
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
18 Feb 20
Other Events
12:00am
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
8 Jan 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:39pm
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
27 Dec 19
Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility
9:03am
8-K
jlkqh
6 Nov 19
Other Events
5:27pm
8-K
9h0j 6tjj8
24 Oct 19
Other Events
4:05pm
8-K
xoeq13
3 Sep 19
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
4:25pm
8-K
o2ml8rwf
9 Aug 19
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
7:37am
8-K
l2aem
16 Jul 19
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
4:50pm
8-K
1afv75
1 Jul 19
Entry into a Material Definitive Agreement
5:18pm
8-K
ok4sliclrc
11 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
wyo7dodfr g8rk0se4d4
7 Jun 19
Other Events
4:31pm
8-K
3usvh 3ci9453487
9 May 19
Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:16pm
8-K
fuwhxi
13 Mar 19
Melinta Therapeutics Reports Fourth Quarter and Full-Year
4:04pm
8-K
69b2q h15
25 Feb 19
Entry into a Material Definitive Agreement
8:15am
8-K
6gma7e4dgaav7il0veh
21 Feb 19
Melinta Therapeutics AnnouncesOne-for-Five Reverse Stock Split
5:22pm
8-K
7i30j8cx3ih
4 Feb 19
Melinta Therapeutics Provides Corporate Updates
9:34am
8-K
2m361673ehsh6s2vb
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
8-K
ot0j8u4ze4sseeyvp
2 Jan 19
Entry into a Material Definitive Agreement
9:57pm